Clinical biochemistry is one of the most explored and reliable branches of clinical diagnostics and pathology. It includes qualitative and quantitative assessment of molecules and chemical entities in given patient sample such as glucose, minerals, electrolytes, and uric acid. These measurements are used to diagnose the functioning capabilities of body organs. Conventional clinical chemistry analysis involves use of various substrates and enzymes or catalysts to detect and quantify the presence of analytes in a given sample based on principles of colorimetry involving light absorption and refraction phenomenon of specific substance at specific wavelength. It includes use of wet reagents, large set-ups, and requires large volume of samples. Dry chemistry analysis, on the other hand, is based on the reflectance measurement of specific substance at specific wavelength and its comparative study with the standards.
Dry chemistry analyzers comprise highly sensitive multilayered reagent coated slides instead of wet reagents. It requires only 10 ml to 50 ml of sample. The results of dry chemistry analyzers are comparable to conventional wet chemistry analyzers. However, results differ for certain parameters among dry and conventional chemistry analyzers. Dry chemistry analyzers are compact and easy to operate, as these do not require storage space for reagents, there is no need for pipetting of reagents, these are semi to fully automatic, and require small volume of sample. These factors have contributed to high adoption of dry chemistry analyzers in acute care settings, physician offices, etc. Dry chemistry analyzers such as blood glucose analyzers, blood cholesterol analyzers, and blood electrolyte analyzers have been widely used across the globe. There are large number of dry chemistry analyzer manufacturers in the market. Major concern among the users is high cost of test cartridges or slides compared to conventional chemistry analyzer reagents. Moreover, most of the analyzers work on closed system principle, with compatibility with own reagent slides or cartridges.
The global dry chemistry analyzers market can be segmented based on product, technology, ergonomics, end-user, and region. In terms of product, the dry chemistry analyzers market can be bifurcated into analyzer systems and consumables. Consumables include reagent coated cartridges or slides, which need to be disposed after each test. Based on technology, the global dry chemistry analyzers market can be classified into single parameter and multi-parameter. These devices have high throughput, which has led to increase in adoption across health care facilities. In terms of ergonomics, the dry chemistry analyzers market can be categorized into benchtop and stationary. Based on end-user, the dry chemistry analyzers market can be divided into hospitals, independent diagnostic laboratories, blood banks, and others.
In terms of region, the global dry chemistry analyzers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The U.S. has high adoption of technically advanced diagnostic devices and preference for point-of-care testing devices. These factors have led to high uptake of dry chemistry analyzers in the U.S. This is attributed to North America’s high share of the global dry chemistry analyzers market in 2017. Europe is projected to account for second the largest share of the global dry chemistry analyzers market owing to well-established health care infrastructure and demand for preventive and quality health care. Large population, high unmet needs, and increase in health care expenditure are anticipated to contribute to the growth of the dry chemistry analyzers market in Asia Pacific during the forecast period.
A large number of suppliers of dry chemistry analyzers compete in the market in terms of extension of test parameters, lowering of test cost, and efficacy of analyzers. Key players in the global dry chemistry analyzers market include Ortho Clinical Diagnostics, Fujifilm Corporation, ARKRAY, Diatest GmbH, ACON Laboratories, Inc., MedTest, Abbott, F. Hoffmann-La Roche Ltd., and Kontrolab.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.